{"id":906100,"date":"2025-11-05T15:57:35","date_gmt":"2025-11-05T20:57:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/"},"modified":"2025-11-05T15:57:35","modified_gmt":"2025-11-05T20:57:35","slug":"biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/","title":{"rendered":"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NESS ZIONA, Israel, Nov.  05, 2025  (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its third quarter 2025 financial results and program updates before the open of the\u00a0U.S.\u00a0financial markets on\u00a0Wednesday, November 12, 2025. The Company will host a conference call and a live audio webcast at 8:30 a.m. ET, to discuss the third quarter of 2025 financial results and provide program updates.<\/p>\n<p>To ensure you are connected prior to the beginning of the call,\u00a0BiomX\u00a0suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.<\/p>\n<p>\n        <strong>Conference Call Dial-In &amp; Webcast Information:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:458.3pt;border-collapse:collapse\">\n<tr>\n<td style=\"width:160.67px;vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Date:<\/p>\n<p>\u00a0<\/td>\n<td style=\"width:450.4px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt\">Wenesday, November 12, 2025<\/p>\n<p>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:160.67px;vertical-align: middle;text-align: left;padding-left: 10.0px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Time:<\/p>\n<p>\u00a0<\/td>\n<td style=\"width:450.4px;border-right: solid black 1pt;border-bottom: solid black 1pt\">8:30 AM Eastern Time<\/p>\n<p><\/td>\n<\/tr>\n<tr>\n<td style=\"width:160.67px;vertical-align: middle;text-align: left;padding-left: 10.0px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Conference Call<\/p>\n<p>\u00a0<\/td>\n<td style=\"width:450.4px;border-right: solid black 1pt;border-bottom: solid black 1pt\">https:\/\/register-conf.media-server.com\/register\/BIf7434533b852452a822a8e5f48b669e2<\/td>\n<\/tr>\n<tr>\n<td style=\"width:160.67px;vertical-align: middle;text-align: left;padding-left: 10.0px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Webcast:<\/p>\n<p>\u00a0<\/td>\n<td style=\"width:450.4px;border-right: solid black 1pt;border-bottom: solid black 1pt\">https:\/\/edge.media-server.com\/mmc\/p\/s6tntmgo<\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>The live and archived\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Nd-Czgm3a3m8ytyzmLD4SXiieA0Rfgi7BzkNJmGW1wZbSfWCXrL4XL41RenkU2J22vKyRAOjfZEJ8opqK5IXIbgtkj216m6zag0cNWmQv1gc5_r1cia_oq-293_dfmCvV6xGIw4_kbHPI8GyrXyd-GxRHabIxFZfwsZNY6P-m-KGsvaUCnuxZtc8ilY4jS3RcDOq0YwvYQjtTzLKqLcH1-7cwO8F0Qc6BGLqC1paSJKqGHw6tp65ahrl63LUf-KiHvsFaiG90ySXV_-TGURIYJkgjIFZFtmixHPjZZewpbC0jXyStDcQ36xBvxPrOsH70Qjid1tV3Ch-soJN6Itfmp-2maqhA5_eEPBRGVq5WJ-gOF6rCMGOV8iKQSb7bokRLH82S9dUJPyTiX33VR37tQ==\" rel=\"nofollow\" target=\"_blank\">webcast<\/a>\u00a0will also be available in the Investors section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xltug18czrrb-Ror2hrpmfAiYLe6sfRVKUgH6MZBdtf19FdNACqFHLSERQz8SaCUMzgWkqSjVJ03xSn34FLI8BJCeprkmJr34GuYHZl9aHgFC9c8WES7aSP9jhTAS5K0q0CbwTusVtvWrSqKQeYTiIalJe25y2tJ4jxnWC3H9T029t3HOPnRUzSslOhPpZTWnO0xTxXen5qLAIoPAzqh4gaNGUdp7OpISWX5YudbnnqAhD03nomES5wJa4AY-_NmAqmbN-JRID0Duz-qftVhJLvX8HuNNaWot4EAg3Op42nR8y-dCv67NNY5miyrsU_WgqaFcQfjzqTutz74sP6L1gO6XkISruYIzFO36aKXejarWOvlKCrE2U8uV1AwwIBYvd2PC7byGt9ld29vTmjSNhwmi8khnltq4mcts_FIN-pg22zr7_D7DNAsj6q743-mUj-ssbkHJmtgoE39smIXTU7mLYE_Illo6Mpbq5TJaXcjOahOoZtd4l69VRERWieV\" rel=\"nofollow\" target=\"_blank\">www.biomx.com<\/a>.<\/p>\n<p>\n        <strong>About BiomX<\/strong><br \/>\n        <br \/>BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (\u201cBacteriOphage Lead to Treatment\u201d) platform to customize phage compositions against these targets. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xltug18czrrb-Ror2hrpmYEywXFye0H3WE5lBWmP1n5VqunI8MBAB9FG6i6LeRf982csWbxLNowGSt3WptxGX9JK3M9-wcfX6KZT-b0PgFRSdhlew-QmZLRlCMvzkcCqxFAsGq3Tb9hR23pxxd25gQnj1Wm8JVclM2hyOBtAL1PjAJQliayXWzWZ4O1hxlmeXamfFHMy3J6OXrYjy39vAUHkBQrQZwGWCC3LyC0Kl-lpvuG5omhbOUAkIsNrtZRv52-dVDm1CNywvE93NFo5cZQXdVE4mQF0CURtj9Up2dgZcz7PkZeKDMRSj_RcnKgT6Y_NQrIf1mMexnm0fm0-hC43vwt9lY8RndCXbor0cSBHg660QRj97sIKzuTYefQk6UAR121bfLGUZd-sMa3X7zqCtDDS8RXB4JxoNM61_sEuIuAEE3zrh0JOyMifQWgiij-QDA8vU7kg8ZO_ITBSOePvcD6ddJJ_iFF5wocVNC5jl11J6qi_cuVPZ_zdWNMlXudnZqDAlRJRxJHuVQXoRh-09wEH5OzViVy23HwT-dcU8kHRueD1tr01iQ2KI2IHPDqAXpIOtCAseVpdMnzNg17OtRiYS0Z0bCY-ZG9_4nZ7VdLeXlM5QdVXRrE2ryBbbudmqIMJ5kxlh7wuRmMRlW9xj5dTsElaluwTSaW4zmpb3VgC_Ln23X2UoaFTBIgd_Y-sesLwmI7FiQHoc1TRwWVG1mYIAux2R955M2lIz4NvTdcKTTUx4XioD99Gc6wKfJQ2iXC_g5viFboRRe_3NBJdg8X5wHJxrhdT7cxVBE85hOcQA-xaEhdswh5S9huk-DVZ2REzBnb_ojbfRHzkrsZAZlNQUJCymDNwteirj0BzNddIZhXjAtYs5iAMZ6aSQopCwHz1cwPsysKb38Y6YWGb-0MwwqHv1FYKfh0SaNqqlPVzk5Kh__XlmVBfjpj_kabJZcg5qgLzYA2Vl6HUCuF7wFckbvfkSVgl81a386pJwN7NOB2k4xEgG6fit_UMI-sTxAwsgFeepuCJVmftGPHUbfFuvo0NYdQxPdZ-gHTlVheVSH-3rkK1wDcvq2_Z5km7Cu4cysaGV3s55qMAkkAh_Slk9FAyPu5_jtlMqV1AN2mvW89P5swVQWT9EuOxJ6Jpz7Fefg8mmaP0BmUEUeSpXjwv3enTKfaHbq11N2JO2MMV8rKxMLJ6IG-GiJ_LThOQ9JHfa8GrIZxuX0MzSBVvMqn-p7POA-yFp9J9v5TMdIM7IEKlJWDGOLoe6s5U_LR8IjwLyoL9IIo-Rom0XeHgqYMjeoK2gArCltBpW8uN5soQ-fOU1ztawHjFNb4_z1mBltNe-V6rseMoCPR5a-ybz2Qm_S1VJSNJN8oDHbKvmRF7MMg96lyol6AqOjENA9Ux3r8TxDrYo2KstEUPtwxWye3cnxYaT_rhtZPTvPVVOv_2If7l3mHilMWzgHq7Tr8WZTKoQJH_uIKyleFaAp9eyu4aSSu3zHsB9Nsfp0gu6Wzb6RGMMKPV1WPLkA_z_vYU76R6IN9eqz4XGOPh2A9OLOof2HlNOOJW02IJfOf54QJEV4kAQLwPXFfAF_MR\" rel=\"nofollow\" target=\"_blank\">www.biomx.com<\/a>, the content of which does not form a part of this press release.<\/p>\n<p align=\"left\">Contacts:<br \/><strong>BiomX, Inc.<\/strong><br \/>Ben Cohen<br \/>Head Corporate Communications<br \/>benc@biomx.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZTNiZTFhYWItZGQxYS00NTE5LTg5MmYtM2MyYTYxNjc5NTNhLTcwMDAyNjEzMy0yMDI1LTExLTA1LWVu\/tiny\/BiomX-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NESS ZIONA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its third quarter 2025 financial results and program updates before the open of the\u00a0U.S.\u00a0financial markets on\u00a0Wednesday, November 12, 2025. The Company will host a conference call and a live audio webcast at 8:30 a.m. ET, to discuss the third quarter of 2025 financial results and provide program updates. To ensure you are connected prior to the beginning of the call,\u00a0BiomX\u00a0suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-906100","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NESS ZIONA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its third quarter 2025 financial results and program updates before the open of the\u00a0U.S.\u00a0financial markets on\u00a0Wednesday, November 12, 2025. The Company will host a conference call and a live audio webcast at 8:30 a.m. ET, to discuss the third quarter of 2025 financial results and provide program updates. To ensure you are connected prior to the beginning of the call,\u00a0BiomX\u00a0suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of &hellip; Continue reading &quot;BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-05T20:57:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025\",\"datePublished\":\"2025-11-05T20:57:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/\",\"name\":\"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz\",\"datePublished\":\"2025-11-05T20:57:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/","og_locale":"en_US","og_type":"article","og_title":"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - Market Newsdesk","og_description":"NESS ZIONA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its third quarter 2025 financial results and program updates before the open of the\u00a0U.S.\u00a0financial markets on\u00a0Wednesday, November 12, 2025. The Company will host a conference call and a live audio webcast at 8:30 a.m. ET, to discuss the third quarter of 2025 financial results and provide program updates. To ensure you are connected prior to the beginning of the call,\u00a0BiomX\u00a0suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of &hellip; Continue reading \"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-05T20:57:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025","datePublished":"2025-11-05T20:57:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/","name":"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz","datePublished":"2025-11-05T20:57:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEzNzEzOSM0MDIyNjAyMTAjNzAwMDI2MTMz"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-report-third-quarter-2025-financial-results-and-program-updates-on-november-12-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/906100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=906100"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/906100\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=906100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=906100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=906100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}